KERALA AYURVEDA
|
|
BOM : 530163     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Jul 05,2022 |
Price(EOD): ₹ 71.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 75.90 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KERALA AYURVEDA | 4.5% | -5% | 24.2% |
SUN PHARMACEUTICAL INDUSTRIES | -0.3% | -3% | 21% |
DIVIS LABORATORIES | 0.7% | 3.1% | -16.5% |
DR REDDYS LABORATORIES | 0.6% | 1.9% | -19.6% |
CIPLA | -0.8% | -3.9% | -4.9% |
GLAND PHARMA | -4.6% | -11.1% | -23% |
PIRAMAL ENTERPRISES | 2% | -5.5% | -29.9% |
CADILA HEALTHCARE | 1.5% | -0.9% | -43.6% |
TORRENT PHARMACEUTICALS | 1.8% | 4.2% | -0.7% |
FUNDAMENTAL ANALYSIS OF KERALA AYURVEDA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KERALA AYURVEDA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-
P/E Calculated based on EPS of -4.59
[ Mar2021 - Consolidated Results ] 193.51
P/B Calculated based on Book Value of 0.37
[ Mar2021 - Consolidated Results ] 1
P/S Calculated based on Revenues of 76.272 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-27% -50% -28% |
SHARE PRICE MOMENTUM OF KERALA AYURVEDA
KERALA AYURVEDA vs SENSEX
DEBT OF KERALA AYURVEDA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
9.4 4.96 4.17 6.18 |
198.95 13.08 16.57 76.2 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KERALA AYURVEDA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KERALA AYURVEDA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
4.68% -54.36% -86.61% -99.81% |
22.73% 280.98% 110.43% 100.14% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
KERALA AYURVEDA related INDICES
You may also like the below Video Courses
FAQ about KERALA AYURVEDA
Is KERALA AYURVEDA good for long term investment?
As on Jul 05,2022, the Fundamentals of KERALA AYURVEDA look Poor and hence it may not be good for long term investment ! See Financial Performance of KERALA AYURVEDA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KERALA AYURVEDA UnderValued or OverValued?
As on Jul 05,2022, KERALA AYURVEDA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KERALA AYURVEDA ?
As on Jul 05,2022, the Intrinsic Value of KERALA AYURVEDA is Rs. 100.07 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 98.32
Fair Value [Median EV / Sales Model] : Rs. 144.21
Fair Value [Median Price / Sales Model] : Rs. 100.07
Median Fair Value of KERALA AYURVEDA : Rs. 100.07
Is KERALA AYURVEDA trading at a Premium or Discount?
As on Jul 05,2022, KERALA AYURVEDA is trading at a Discount of -28% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
